ARCN1 and cancer: Importantly, ARCN1 (δ-COP) knockdown has previously been shown to significantly impair the viability of cancer cell lines by potentiating activation of the UPR and inhibiting phosphatidylinositol 3-kinase (PI3-kinase)/Akt signalling [36].